Abstract
Stroke and cardiac arrest claim the lives of millions worldwide each year emphasizing the importance of understanding this injury cascade. These pathologies present as a ‘two hit’ injury termed ischemia/reperfusion (I/R) injury. The primary injury is the initial disruption of blood flow and ischemic state while the secondary injury, paradoxically, being the return of blood flow and oxygen availability. The injury caused by reperfusion presents a viable window for therapeutic intervention, stressing the importance of understanding this injury pathology. Constantly undergoing fission and fusion, mitochondria are dynamic organelles that play a vital role in maintaining cell health and are highly susceptible to I/R injury. Following I/R injury, disrupted mitochondrial dynamics and quality control ultimately lead to a dysfunctional mitochondrial network, energy depletion and eventually cell death. While mitochondrial dynamics and quality control have been studied extensively in the realm of I/R injuries, the role of mitochondrial lipids is emerging as an important component of injury progression. The inner mitochondrial membrane lipid, cardiolipin has been demonstrated to play an integral role in maintaining mitochondrial quality control, dynamics and energy production. In response to oxidative stress, cardiolipin has been shown to interact with several important proteins involved in mitochondrial dynamics while also contributing to integral signaling cascades. This review will highlight the role of cardiolipin in mitochondrial dynamics and quality control in response to neuronal I/R injury.
Similar content being viewed by others
Facts
-
Mitochondria are dynamic organelles that constantly undergo fission and fusion to maintain a healthy mitochondrial network and cellular homeostasis.
-
Following ischemia/reperfusion injury, mitochondrial dynamics are impacted resulting in a dysfunctional mitochondrial network, inadequate energy reserves and impaired cell health.
-
Mitophagy, the selective degradation of damaged mitochondria can be either neuroprotective or detrimental during reperfusion, demonstrating the fragility of the mitochondrial network.
-
Cardiolipin, an essential phospholipid found almost exclusively on the inner mitochondrial membrane, contributes to mitophagy and mitochondrial dynamics following neuronal ischemia/reperfusion injury.
-
Through its interaction with key dynamic proteins and its role in mitophagy, cardiolipin is through to contribute to neuronal ischemia/reperfusion injury pathology.
Introduction
Cerebral ischemia/reperfusion (I/R) injuries, including stroke and cardiac arrest, are leading causes of death and disability worldwide [1, 2]. The mammalian brain requires oxygen, glucose, and other metabolites supplied through cerebral circulation for metabolism and function [3,4,5]. During ischemia, blood flow to the brain is disrupted, leading to depletion of ATP and an eventual state of energy deprivation. Cerebral ischemia induces primary injury via neuronal damage, glial activation, and endothelial cell dysfunction [6,7,8]. Prompt reperfusion to restore oxygen and nutrient delivery is critical for limiting ischemic injury [9,10,11]. Reperfusion is necessary to salvage ischemic tissue, however it also induces secondary cellular death and delayed cerebral injury [12]. Reperfusion injury is a significant contributor to brain damage related to cerebral ischemia, however progressive development of the injury offers a treatment window to improve outcomes. Understanding the mechanisms driving I/R injury is critical to advancing our ability to limit reperfusion injury.
The energy production capacity and overall health of a cell are dependent on the maintenance of mitochondrial homeostasis. The mitochondrial life cycle is dictated by several physiological mechanisms, including both mitochondrial dynamics and quality control. Mitochondria are dynamic agents that constantly undergo fission and fusion to maintain mitochondrial architecture [13]. Fission acts to segment mitochondria for the isolation and removal of damaged proteins, mitochondrial DNA mutations, and dysfunctional components [14, 15]. In contrast, fusion constructs and stabilizes mitochondrial networks to promote efficient energy production and mitochondrial matrix equilibrium [16, 17]. Together, fission and fusion dynamics coordinate the mitochondrial network to protect and preserve efficient function and homeostasis [18]. Mitochondrial quality control acts to maintain healthy mitochondria while selectively degrading dysfunctional components through mitophagy. Under ischemic stress, mitochondria release damage associated with molecular patterns (DAMPs) (ie mDNA, TNFa, IL-6) that trigger inflammatory pathways which activate microglia and astrocytes further contributing to the immune response. Following I/R injury, the electron transport chain (ETC) produces mitochondrial reactive oxygen species (ROS). This initiates several intracellular cascades, including an increase in intracellular calcium which can cause opening of the mitochondrial permeability transition pore (mPTP), which contributes to the collapse of the membrane potential. These mechanisms play a critical role in disrupting mitochondrial dynamics and quality control, resulting in a dysfunctional mitochondrial network and inadequate energy reserves.
Recently, lipids have been shown to play a crucial role in mitochondrial quality control and mitophagy [19,20,21,22,23]. Much like proteins, lipids undergo peroxidation when exposed to ROS. Peroxidation alters the physical structure and composition of lipids which can disrupt the structural integrity of cellular membranes [24]. As a double membrane organelle prone to ROS generation, the mitochondria is highly susceptible to structural disruption of either the inner mitochondrial membrane (IMM) or the outer mitochondrial membrane (OMM). Cardiolipin (CL) is an essential phospholipid found almost exclusively in the inner membrane of the mitochondria contributing to cristae structure and cellular respiration. In addition to maintaining membrane integrity, cardiolipin plays mechanistic roles in mitochondrial dynamics, quality control, programmed cell death and cellular respiration [22]. The aim of this review is to detail how CL contributes to the interactions between mitochondrial dynamics and quality control under basal conditions and in response to neuronal I/R injury.
Cardiolipin metabolism and function
CL is composed of a glycerol head group and two phosphatidate moieties consisting of four alkyl chains. This allows for two forms of asymmetry: molecular and trans-membrane asymmetry. The molecular asymmetry makes CL structurally complex with a variety of subspecies that express tissue specificity. Due to the two chiral centers, two CL subspecies that have four, molecularly identical acyl chains will still maintain two chemically distinct phosphatidyl moieties [25]. The trans membrane asymmetry refers to the uneven distribution of CL between the IMM and the OMM. CL is found almost exclusively in the IMM where it plays a crucial role in supporting membrane curvature. Due to this dimeric structure, cardiolipin holds a conical shape that when clustered, this shape supports cristae curvature and plays an important role in inner membrane support. The overall energy demand of the membrane decreases when lipids of high intrinsic curvature, such as CL, form clusters at polar regions of the membrane, stabilizing the geometric curve of the IMM [26]. Within the inner membrane, CL has been shown to bind and stabilize complex III and IV within the ETC [22, 27]. When bound CLs are disrupted, the ETC becomes inactive and the ETC subunits dissociate [28]. The proposed mechanism by which CL regulates programmed cell death and autophagy is through its affinity for cytochrome c. Under basal conditions, cytochrome c is tethered to CL in the IMM, but when exposed to oxidative stress, CL is externalized, facilitating release of cytochrome c into the cytosol, and inducing programmed cell death [29, 30].
The biosynthesis of CL begins with phosphatidic acid (PA) import into the mitochondrial matrix and conversion to cytidine diphosphate diacylglycerol (CDP-DAG) by the membrane bound protein Tamm41. Phosphatidyl glycerophosphate synthase 1 (PGS1) converts CDP-DAG into p-glycoprotein (PGP) which is then converted to phosphatidylglycerol by protein tyrosine phosphatase mitochondrial 1 (PTPMT1). PG is then converted to premature CL by cardiolipin synthase 1 (CRSL1). The production of premature CL signals the end of the “biosynthesis” phase and marks the “remodeling” phase (Fig. 1). At the conclusion of biosynthesis, premature CL is formed and then remodeled into mature CL. The distinguishing feature between premature and mature CL is the degree of saturation of the fatty acid tails [31]. Following biosynthesis, the structural remodeling process cleaves and re-acylates the fatty acids of CL. Remodeling is driven by the enzyme Tafazzin (TAZ), a transacylase that transfers fatty acids from phospholipids to lysophospholipids [32]. During remodeling, saturated fatty acid tails of premature CL are cleaved by a member of the iPLA2 family to form the intermediate monolysocardiolipin (MLCL). TAZ re-acylates MLCL with unsaturated fatty acid tails to form mature CL (Fig. 1). When this remodeling process is disrupted, MLCL accumulation can contribute to mitochondrial dysfunction through lipid pore formation and collapse of the membrane potential [33]. The accumulation of MLCL through TAZ dysfunction is extensively studied in cardiac tissue due to its relevance in Barth Syndrome and contribution to fatal dilated cardiomyopathy [34]. However, its role in neuronal I/R injury is largely unknown. In one study, juvenile rats exposed to global cerebral I/R injury resulted in an increase of caspase 3/7 activation and hydrolysis of CL to lyso- and MLCL [35]. The accumulation of MLCL is thought to dysregulate mitophagy, contributing to dysfunctional mitochondrial dynamics and quality control by disrupting cristae curvature and membrane integrity [36].
Biosynthesis begins with PA being converted to cytidine diphosphate diacylglycerol (CDP-DAG) by the membrane bound protein Tamm41. CDP-DAG then interacts with phosphatidyl glycerophosphate synthase 1 (PGS1), another membrane bound protein, producing p-glycoprotein (PGP). Protein tyrosine phosphatase mitochondrial 1 (PTPMT1) then converts PGP to PG. Biosynthesis is then concluded with cardiolipin synthase (CRLS1) converts PG to premature cardiolipin (CL). Once premature cardiolipin is produced the remodeling process begins. A membrane of the iPLA2 family cleaves one of the fatty acyl chains of the premature cardiolipin and replaces it with a hydroxyl group producing the intermediate monolysocardiolipin (MLCL). Tafazzin then re-acylates monolysocardiolipin with an unsaturated fatty acid chain producing the more stable mature CL. The main difference between premature and mature cardiolipin is the degree of saturation, with the mature form consisting of more unsaturated fatty acid tails resulting in a more stable cardiolipin.
Mitochondrial dynamics
As dynamic organelles, mitochondrial structure is continually regulated by several mechanisms to optimize energy production for the cell. Mitochondrial dynamics ensure that the network responds to the needs of the cell through fission and fusion (Fig. 2).
Dimerization of mitofusin 1 and 2 (Mfn1/2) brings two mitochondria closer together to begin outer membrane fusion. Inner mitochondrial membrane fusion is driven by optic atrophy 1 (Opa1), which creates protrusions on the inner membrane and begin matrix fusing. Mitochondrial fission (lower row) is actuated by post-translational modification of dynamin-related protein 1 (Drp1) and accumulation of Drp1 receptors on the outer mitochondrial membrane. Drp1 forms an oligomeric ring around the site of fission. ER tubules come in close association with the fission site to complete division.
Mitochondrial fission
Mitochondrial fission is executed by the GTPase dynamin-related protein (Drp1) and can be driven by calcium transients, ROS, electron transport chain integrity, and mitochondrial membrane potential, although it is experimentally difficult to determine the singular causality of each of these variables [37,38,39,40]. Normally residing in the cytosol, Drp1 translocates to the OMM upon activation by post-translational modifications and an increase in cytosolic Ca2+ [41, 42], thereby regulating mitochondrial fission (Fig. 3). In hippocampal neurons, an increase in calcium influx via voltage gated dependent calcium channels resulted in an increase in mitochondrial fission via phosphorylation of Drp1 at s600 by CamK1alpha [43]. Further, phosphorylation of Drp1 at s656 by cyclic AMP dependent protein kinase A resulting in mitochondrial elongation is driven by increased calcium levels while dephosphorylation of s656 results in mitochondrial fragmentation [41].
Once translocated to the OMM, Drp1 can interact with several OMM receptors that are known to initiate mitophagy such as mitochondrial fission factor (Mff), mitochondrial fission protein 1 (Fis1) and mitochondrial dynamic proteins (MiD49/MiD51). Externalized cardiolipin (CL) has recently been shown to interact with and stabilize translocated Drp1.
Upon recruitment to the OMM, Drp1 interacts with four major receptors: Fis1, Mff, MiD49, MiD51, and MCL-1 [44,45,46]. While interactions between Drp1 and all four receptors are capable of executing fission, Mff (basal/physiological fission) and Fis1 (stress-induced fission) are the best characterized receptors (Fig. 3) [44, 47, 48]. In mouse embryonic fibroblasts, Mff gain and loss of function experiments resulted in significant activation or reduction of mitochondrial fission, respectively [44, 49]. Through the N-terminus, Mff binds Drp1 and promotes the formation of Drp1 oligomers and promotes mitochondrial fission [50]. In vivo and in vitro studies overexpressed saturated and unsaturated fatty acids individually and observed an increase in mitochondrial fission in the unsaturated fatty acid condition and increase in mitochondrial elongation in the saturated fatty acid condition [51]. This suggests that Drp1 is interacting directly with the headgroups of unsaturated phospholipids to induce the hydrolysis and scission of the mitochondrial membrane. In yeast, the Drp1 homolog, Dnm1, was observed to promote mitochondrial fission through self-assembly and GTP hydrolysis [52]. Cryo-EM of purified Drp1 revealed structural changes after Drp1 GTP hydrolysis, which leads to Mid49 dissociation and the shortening and curling of Drp1 oligomers promoting scission of the membrane [53]. Taken together, under basal conditions, Drp1 interacts with unsaturated membrane phospholipids and Mff to promote membrane scission via GTP hydrolysis across several experimental models.
Mitochondrial fission 1 protein (Fis1) has been implicated in stress-responsive mitochondrial fission. Fis1 is embedded in the OMM where its N-terminal 1a helix protrudes into the cytosol to bind cytosolic Drp1. When the 1a helix is mutated, Drp1 interactions are destabilized and fission cannot proceed, impacting mitochondrial morphology and overall bioenergetics [54]. The phosphorylation of Fis1 is critical for mitochondrial fission following oxidative stress [55]. In vivo and in vitro studies pharmacologically inhibiting the phosphorylation of Fis1 result in elongated mitochondrial morphology and improved cellular respiration following I/R injury [56].
Myeloid cell leukemia factor-1 (MCL-1) is also thought to promote mitochondrial fission through its interactions with Drp1. MCL-1 can be sliced into long and short isoforms (MCL-1S and MCL-1L, respectively). In vitro studies demonstrated that an increase in MCL-1S:MCL-1L contributes to hyperpolarization of the mitochondrial membrane potential and accumulation of Ca2+contributing to altered mitochondrial morphology and impact on the functionality of the mitochondrial network [57]. Autophagy was also observed to be increased in cortical neurons in MCL1 knockout mice, suggesting that MCL1 plays a critical role in mitochondrial quality control through its involvement in Drp1 mediated fission [58].
CL is also proposed to have a role in promoting Drp1 mediated fission. NMR experiments identified CL’s binding motif to be conserved with Drp1, suggesting a role in mitochondrial dynamics and a codependent relationship with Drp1 to promote network fragmentation following oxidative stress (Fig. 3) [59]. Cryo-EM studies further support the role of CL in Drp1-dependent fission, demonstrating that CL binding alters the Drp1 helical structure promoting GTPase activity and oligomerization [60]. Fluorescence spectroscopy studies were able to further elucidate the mechanism by which CL-Drp1 dependent fission occurs [61]. With high spatial density in the target lipid bilayer, recruited Drp1 is stabilized by CL localization, specifically the unconstrained, non-raft-associated, fluid-phase CL. These associations prime the membrane for remodeling where GTP hydrolysis is stimulated, which further induces CL rearrangement. The tendency of CL to undergo the transformation from a lamellar, bilayer arrangement to a hexagonal, non-bilayer arrangement while Drp1 and GTP are present, prime localized regions of the membrane for fission [61]. Oxidative stress promotes CL externalization to the OMM, suggesting that this externalization promotes Drp1 stability and can induce fission, revealing yet another vital role that CL has in maintaining a healthy mitochondrial network.
Mitochondrial fusion
Mitochondria are double membrane organelles and fusion requires merging of both the inner and outer membranes through distinct machineries. The key players in fusion of the OMM are the GTPases mitofusins 1 and 2 (Mfn1 and Mfn2) [62]. Upon GTP binding, Mfn1/2 unfold and adopt a stalk-like structure where they can form homo-oligomers or hetero-oligomers (Mfn1-Mfn1/Mfn1-Mfn-2/Mfn2-Mfn2) between the two adjacent mitochondria allowing fusion to occur (Fig. 4) [62,63,64]. In mice, knockouts of either of Mfn1/2 are lethal, but in vitro cell cultures are viable and result in a highly fragmented mitochondrial network [62, 64].
Similar to fission, mitochondrial fusion has bidirectional relationships with changes to the mitochondrial environment, including ROS, Ca2+, and bioenergetics [37]. Oxidized glutathione has been shown to drive fusion in HeLa cells and mouse embryonic fibroblasts [65]. Oxidized glutathione accumulation generates disulfide-mediated Mfn oligomers, thus priming the machinery required for fusion following exposure to cellular stress [66]. In vivo and in vitro studies found an increase in fusion following starvation, likely a response to limit oxidative stress to the mitochondrial network [67]. Consistent with fission, cytosolic Ca2+ levels have recently been suggested to play a role in modulating mitochondrial fusion [68]. This suggests that Ca2+ could affect mitochondrial homeostasis by promoting fission through stabilization of Drp1, while simultaneously impairing fusion.
At the IMM, optic atrophy 1 (Opa1) mediates both inner membrane fusion and cristae dynamics. Opa1-mediated membrane fusion requires a balance of short (S-Opa1) and long (L-Opa1) Opa1 isoforms [69, 70]. In HeLa cells, there are eight isoforms that are post-translationally cleaved, where long and short isoforms interact to regulate mitochondrial dynamics and morphology [70]. Long isoforms (L-Opa1) contain an N-terminal transmembrane anchor, whereas short isoforms (S-Opa1) do not [71, 72]. In vitro reconstitution of L-Opa1 and S-Opa1 individually and concurrently uncovered that both are necessary for proper fusion of the IMM [71], a result that has been replicated in yeast and cell culture [72, 73]. L-Opa is thought to contribute more to fusion while S-Opa contributes more to cristae support and mitochondrial energetics [71, 74]. Overexpression of S-Opa1 in an in vitro showed inhibition of fusion, whereas L-Opa1 alone was capable of membrane docking and content release [71]. Following oxidative stress, the mitochondria is depolarized resulting in Oma1 dependent cleavage of Opa1 (Figs. 4) [75].
During fusion, Opa1 oligomers create membrane protrusions with limited stability on adjacent OMMs. Mitochondrial contact site and cristae organizing system drive the structural organization and priming of the IMM and cristae for fusion [76, 77]. Lipid mixing between the two protruding membranes forms a fusion pore that can progress to complete fusion by Opa1 GTPase activity [78]. Interestingly, fusion of the IMM is CL dependent. The intermembrane space domain of L-Opa1 binds CL on the opposing membrane, forming a heterotypic dimer and in a GTP independent manner while priming fusion of the inner membranes (Fig. 4) [78]. L-Opa1-CL fusion occurs in a GTP dependent manner, with double the liposomes observed in the presence of GFP [71]. Purified human L-Opa1 was sufficient to interact with CL on opposing membranes and successfully fuse mitochondrial membranes in vitro, whereas purified human S-Opa1 was not sufficient to induce membrane fusion [79]. These studies support the necessity of L-Opa1 and CL interactions for proper membrane fusion through formation of heterotypic dimers on the opposing inner membranes and that S-Opa1 acts as a supporting role during tethering.
Mitochondrial dynamics in I/R
Mitochondrial dynamics are known to be highly active during cerebral I/R injury and can modulate injury progression and severity. Opa1 processing appears to be a central component of mitochondrial fragmentation following I/R injury. HT22 cells exposed to oxygen glucose deprivation and reoxygenation (OGD/R) and rats exposed to global ischemia and reperfusion displayed an increase in Opa1 processing as well as cytochrome c release to the cytosol, activation of caspase 3/7 and initiated programmed cell death [80]. Similarly, following OGD/R in primary neurons and middle cerebral artery occlusion (MCAO) in mice, an increase in Opa1 cleavage was observed resulting in an accumulation of S-Opa1 contributing to excessive fragmentation of the mitochondrial network [81]. Accumulation of succinate, due to the reversal of succinate dehydrogenase following I/R injury, has been shown to drive fragmentation of the mitochondrial network [82]. This initial wave of fragmentation is generally attributed to ROS production at the onset of ischemia and broad mitochondrial depolarization throughout the ischemic phase [83]. The onset of reperfusion is thought to generate a large amount of ROS during the initial moments of reoxygenation [84]. Despite this ROS burst, mitochondrial fission slows or halts during early reperfusion, with variable onset of mitochondrial fusion [80, 84,85,86]. Intriguingly, fusion slows during the later stages of reperfusion, bringing forth a secondary wave of fission [80, 84, 86]. Primary neurons isolated from mt-Keima (a fluorescent mitophagy reporter) mice exposed to OGD/R showed a primary wave of fission at 6 h reperfusion and a secondary wave at 24 h reperfusion [86]. A similar result was found in a mouse model of neonatal hypoxic ischemic encephalopathy, where there was a primary wave of fission and fragmentation following the hypoxic ischemic insult (3 and 8 h reperfusion) and a secondary wave at 7 days [86]. Although the time scales differ with respect to model and severity of injury, it is clear that an initial wave of mitochondrial fragmentation occurs proximal to injury followed by a delayed, secondary wave. Upregulation in fission results in a fragmented mitochondrial network and an overall decrease in cellular energy reserves, commonly contributing to programmed cell death. A proposed hypothesis is that the initial fragmentation is a pathological response to the injury, followed by bioenergetic failure, high ROS production and mitochondrial permeability transition, which leads to a delayed secondary wave of fragmentation [80, 86,87,88]. Critically, modulation of mitochondrial dynamics can improve outcomes after neuronal I/R injury. Many studies targeted the initial wave of fission in the early stages of reperfusion by modulating Drp1 activity. Genetically ablation of Drp1 activating subunit (Bβ2) mitigated excessive fission and increased mitochondrial elongation which had an overall neuroprotective effect through increased respiratory capacity, stabilized Ca2+ levels, and reduced ROS production following I/R injury [89]. Pharmacological inhibition of Drp1 resulted in restoration of mitochondrial membrane potential following OGD/R in HT22 cells and a reduction in cerebral infarct in mice exposed to transient focal ischemia [89,90,91,92,93]. Additional studies focused on the role of fusion and expression of Mfn2 during reperfusion. Under normal and hypoxic conditions, Mfn2 depletion lead to an increase in programmed cell death, but overexpression of Mfn2 in hypoxic conditions increases cellular viability and provides neuroprotection through increased autophagosome formation and promotion of fusion [89,90,91,92,93]. Consistently, overexpression of L-Opa1 rescued mitochondrial morphology and improved overall cell viability in primary neuronal cultures exposed to I/R injury [89,90,91,92,93].
Mitochondrial quality control
Maintenance of mitochondrial homeostasis is mediated by mitophagy which remodel and adapt mitochondria and their essential components. Defects in these mitochondrial quality control pathways are linked to neurological diseases and injuries.
PINK1/Parkin mitophagy
Mitophagy, the selective autophagic degradation of mitochondria, includes engulfment of whole mitochondria as well as selective removal of mitochondrial components via mitochondrial derived vesicles [94, 95]. The best characterized form of mitophagy in neurons is the stress-responsive PINK1-Parkin pathway (Fig. 5). The kinase PINK1 is continually imported into mitochondria under basal conditions where it is quickly degraded by intramitochondrial proteases PARL and LonP1 [96, 97]. When mitochondria become depolarized, PINK1 import is halted, leading to accumulation of PINK1 on the OMM [96, 98]. At the mitochondrial surface, PINK1 phosphorylates nascent monomers and ubiquitin chains on OMM proteins, recruiting Parkin, a cytosolic-residing E3 ubiquitin ligase [99,100,101]. Similar to ubiquitin, PINK1 phosphorylates Parkin at S65 on its ubiquitin-like-domain to activate Parkin activity [102,103,104]. Parkin activation leads to ubiquitination of key OMM proteins, such as VDAC, hexokinase I, Tomm20 and RHOT1/2, generating more polyubiquitinated substrates for PINK1 kinase activity [100, 105,106,107]. Phosphorylation of Parkin-constructed ubiquitin chains stabilizes Parkin translocation and creates a feedforward loop between PINK1 and Parkin [102]. Although the specific linkage type of polyubiquitin chains on substrates determines the fate of the substrate, the majority are associated with initiation of macro-autophagy [108, 109]. K63-linked ubiquitin chains and ubiquitin monomers phosphorylated by PINK1 at S65 recruit the autophagy adapters Optineurin (OPTN), p62, and NDP52 to damaged mitochondria [99, 110,111,112,113,114]. Autophagy receptors then recruit LC3-expressing phagophores to mitochondria for engulfment, with conditional necessity of phosphorylation by the kinase TBK1 [113, 115]. Once the mitochondria is completely sequestered by the phagophore, it matures into an autophagosome that will eventually fuse with the lysosome for breakdown of the mitochondrial components.
Import of PINK1 is dependent on mitochondrial membrane potential, when the membrane is depolarized the import of PINK1 comes to a halt, leading to its accumulation on the OMM. PINK1 then phosphorylates ubiquitin monomers and chains to recruit Parkin, an E3 ubiquitin ligase which is also phosphorylated by PINK1, generating more ubiquitin chains on the OMM. The phosphor-ubiquitin chains recruit autophagy receptors (e.g., OPTN) to mitochondria and eventually bind to microtubule associated protein light chain 3 (LC3) on photophores to initiate macro-autophagy.
Cardiolipin mitophagy
The PINK1/Parkin pathway occurs under basal conditions, as general housekeeping to maintain a healthy mitochondrial network, however following injury, CL externalization is thought to induce mitophagy. When there is a decrease or partial collapse of the membrane potential, CL is externalized to the OMM where it contributes to CL-dependent mitophagy [25]. When CL is unbound from the IMM it is translocated to the OMM by phospholipid scramblase-3 (PLS3) where it is externalized and recognized by LC3 on the autophagosome (Fig. 6) [35, 116, 117]. Until fusion with the lysosome, membrane-bound lipidated LC-3II will remain attached to the autophagosome. Interestingly, LC-II has binding affinity with externalized CL [35]. The rate of mitophagy decreases in HeLa cells, SH-SY5Y cells, and in primary culture neurons when PLS3 is inhibited, preventing the translocation of CL to the OMM and supporting the role of CL in mitophagy initiation [35, 116, 117]. Another mechanism in which CL can contribute to mitophagy is through Beclin 1. In mitochondria, externalized CL has been shown to interact with Beclin 1, resulting in an induction of mitophagy [118]. Both of these interactions suggest the role of CL in inducing mitophagy in response to stress in various models.
Cardiolipin typically found on the inner mitochondrial membrane is translocated by phospho scramblase 3 (PLSCR3) to the outer membrane following oxidative stress or reactive oxygen species (ROS) accumulation. Once externalized, cardiolipin is recognized by microtubule associated protein light chain 3 (LC3) on autophagosomes, initiating macro-autophagy.
Mitochondrial quality control in I/R
The role of mitophagy in clearing damaged and dysfunctional mitochondria suggests it is an important component of recovery from I/R injury. In cell animal models of I/R injury, autophagy and mitophagy machinery are upregulated, along with mitophagic flux [68, 119,120,121]. Despite extensive study, the importance and timing of mitophagy induction remain unclear with reports of activation in the ischemic and reperfusion phases of injury [68, 119,120,121]. These studies focused on various timepoints of reperfusion ranging from immediately following reperfusion to 24 h after, all reporting significant upregulation in mitophagy [122,123,124].
While the occurrence of mitophagy following I/R injury is well-documented, the relationship between mitophagy and neurological outcomes after I/R injury is debated. Conflicting reports in similar models present mitophagy as either neuroprotective or an overactive mechanism potentiating mitochondrial dysfunction. Autophagy inhibition (pharmacological and genetic) during reperfusion exacerbates neuronal injury [121]. This suggests that autophagy can be protective during reperfusion, likely attributed to mitophagy related mitochondrial clearance. Similarly, PINK1 knockout exacerbated cell death and cerebral infarct volume in models of I/R injury, whereas overexpressing PINK1 had a rescue effect [125]. These results are supported by evidence that overexpressing PINK1 provides neuroprotection by preventing the release of cytochrome c and mitigating programmed cell death through improved mitochondrial function [126]. Under basal conditions PINK1/Parkin machinery are involved in the biogenesis of mitochondrial derived vesicles responsible for discarding dysfunctional mitochondrial proteins to maintain mitochondrial homeostasis and a functional network [95]. Following injury, there is an accumulation of oxidative stress that stimulates PINK1/Parkin mitophagy and possibly contributes to an increase in mitophagy and degradation of the mitochondrial network. Activation of mitochondrial degradation could lead to insufficient energy reserves and an overall decrease in cell health.
Interplay between mitochondrial dynamics and QC pathways
Mitochondrial dynamics and quality control systems display coordinated activity to maintain mitochondrial homeostasis. Among the best characterized relationships is the isolation and clearance of dysfunctional mitochondria through fission and mitophagy [14]. In the context of cerebral injury, increased mitochondrial fission precedes the surge in mitophagy, although this relationship may be correlative as both fission and mitophagy are triggered by mitochondrial depolarization and dysfunction [127,128,129,130]. Evidence supports a causal role of fission and mitophagy in neuronal injury. The predominant paradigm suggests limiting fission and augmenting mitophagy is neuroprotective. Tang et al. demonstrated reduced mitochondrial damage and rescue of Neuro2a cells by Drp1 knockdown or Parkin overexpression prior to OGD/R, concluding that Parkin-mediated mitophagy can be protective through degradation of excessive Drp1 mediated fission [131]. Further, an upregulation in Parkin mediated mitophagy was observed in hippocampal neurons following transient global cerebral ischemia and improved neurological outcomes [132]. Differentiating mitophagy and autophagy, in vitro studies showed that moderate levels of ROS induced Drp1-dependent mitophagy but not non-selective autophagy [128]. Additional studies expanded on this, demonstrating that Fis1 can stimulate non-selective autophagy but only in response to mitochondrial function rather than stimulating fission and ultimately mitophagy [127,128,129,130]. Further, when mitochondria undergo fission, depending on where fission is occurring on the membrane, they produce two daughter mitochondria. One daughter mitochondria has higher membrane potential with higher probability of undergoing fusion and one has a lower membrane potential with a higher probability of undergoing mitophagy [127,128,129,130]. When taken together, these studies imply a strong connection between fission and mitophagy, isolation of damaged mitochondria followed by its degradation. Burman et al. proposed a more nuanced model in which Drp1-mediated mitochondrial fission acts a protector of healthy mitochondria by severing dysfunction segments, allowing for PINK1/Parkin mitophagy to proceed only on fission-produced dysfunctional mitochondria [133]. Aside from PINK1/Parkin mitophagy, Drp1 is required for the biogenesis of mitochondrial-derived vesicles, which act to selectively remove mitochondrial proteins and mitochondrial DNA-containing nucleoids [95, 134, 135]. As a part of the pseudo-ubiquitin cascade that occurs during PINK1/Parkin mitophagy, the outer membrane fusion protein Mfn2 becomes ubiquitinated. Ubiquitination of Mfn2 can lead to both selective degradation of Mfn1/2 complexes, as well as increased autophagy receptor recruitment for mitophagy initiation, thereby inhibiting fusion and enhancing mitophagy [108, 136]. Similarly, Mfn2 inhibition and knockout decreases general autophagy and mitophagy, and Mfn1 overexpression increases mitophagy, further strengthening this relationship [136,137,138,139]. These effects may be specific to Mfn1/2 rather than fusion, as overexpression of Opa1 leads to decreased mitochondrial sequestration in autophagosomes [130]. Many outstanding questions remain as to the relationships between mitochondrial fusion and mitochondrial quality control pathways that prompt further investigation.
Although CL dependent mitophagy is well established, the possibility that it contributes to other forms of mitophagy is well supported. In several in vitro models, increase in the expression of CL, which is thought to rescue the complex 1 deficits seen in the PINK1 mutants [140]. The mechanism by which this is occurring is not entirely known, but the increase in CL expression is thought to restore the electron transfer between complex 1 and ubiquinone [140]. In the context of acute lung injury, PINK1 was shown to bind to and degrade cardiolipin synthase 1 (CRLS1) and decrease overall CL expression resulting in dysfunctional mitochondria and increased programmed cell death [141]. These effects were restored in PINK1 knockout mice and overall acute lung injury was decreased. Although these interactions are in the realm of neurological disorder and mitochondrial injury, they suggest that CL regulates mitochondrial health on a grander scale than current literature suggests.
In addition to mitophagy, CL plays several roles in I/R injury and overall mitochondrial stress response. Due to its molecular and chemical structure, CL has a strong ability to form non-covalent interactions with several proteins involved in cellular respiration (complex I, II, IV, and V), carrier proteins (ADP-ATP carrier, phosphate carrier, uncoupling protein) and peripheral membrane proteins (cytochrome c and creatine kinase) [142]. In vitro I/R studies showed that exogenous oxidized CL lowered the Ca2+ threshold for opening the mitochondrial mPTP and promoting the release of cytochrome c from the mitochondria [143]. When Ca2+ levels increase, CL becomes oxidized which destabilizes its non-covalent interactions with a number of proteins outlined above, which can contribute to several mitochondrial stress responses, including opening of the mPTP. Further, CL content increases in response to mitochondrial stress which can stabilize mtDNA, a known DAMP which contributes to the immune response. ROS also triggers an increase in peroxisome proliferator-activated receptor gamma coactivator-1α (PGC1α) which promotes mitochondrial biogenesis as an attempt to restore energy production and reestablish a healthy mitochondrial network. Interestingly, recent studies have shown that CL synthesis is influenced by PGC1α [144]. As an integral phospholipid, CL plays several crucial roles not only to membrane integrity but also to maintaining healthy mitochondria, individually and as a network as a whole.
Conclusions
Mitochondria are dynamic organelles that have complex physiology in order to maintain a healthy network and adequate cellular energy supply. Mitochondrial dynamics and quality control are an integral part of maintaining mitochondrial network homeostasis. While basal levels of fission and mitophagy maintain a healthy mitochondrial network, overactive fission can result in a fragmented, dysfunctional mitochondrial network. Mitochondrial fusion is the primary mechanism of equilibration across the mitochondrial network of a cell, as few other mechanisms exist for distribution and dispersal of mitochondrial proteins, DNA, and metabolites. When either the outer or inner mitochondrial membrane cannot properly fuse, the result is a fragmented mitochondrial network with decreased cellular respiration and energy reserves. Further work is required to disentangle the beneficial and detrimental effects of mitophagy in I/R, however, much of the variability may be related to injury severity, neuronal cell types and model organisms.
Lipids are highly susceptible to the oxidative injury characterized in I/R injury. CL is an essential phospholipid found on the IMM that contributes to cristae structure, membrane curvature and cellular respiration. Due to the variety and tissue specificity of the four acyl chains and their sensitivity to oxidation, CL has also been used as a biomarker in several diseases and disorders. In the early pathology of Type II diabetes, oxidized CL has been observed in circulating plasma [145]. Altered CL profiles have been observed in Alzheimer’s and Parkinson’s Disease [146]. Neuronal specific CL has been found in circulating blood and used to predict injury severity in rodent models of pediatric traumatic brain injury and adult cardiac arrest [147, 148]. As identification techniques advance, the role of CL in injury and disease pathologies can be more accurately and reliably assessed. Advanced mass spectrometry methods would improve investigation into how the acyl chains respond to and are altered by oxidative stress which will allow researchers to better understand how membrane dynamics play a role in injury progression. With this information, better diagnostics, therapeutics, and pharmacological interventions could be designed. Research is just scratching the surface with CL as new findings are uncovering novel relationships between CL and known proteins involved in mitochondrial dynamics and quality control and the importance of these mechanisms to I/R injury.
References
Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke. 2023;54:1330–9.
Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97:S6–16.
Catchlove SJ, Macpherson H, Hughes ME, Chen Y, Parrish TB, Pipingas A. An investigation of cerebral oxygen utilization, blood flow and cognition in healthy aging. PloS One. 2018;13:e0197055.
Li H, Guglielmetti C, Sei YJ, Zilberter M, Le Page LM, Shields L, et al. Neurons require glucose uptake and glycolysis in vivo. Cell Rep. 2023;42:112335.
Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36:587–97.
Constantakis JW, Reed-McBain CA, Famakin B. Astrocyte innate immune activation and injury amplification following experimental focal cerebral ischemia. Neurochem Int. 2023;162:105456.
del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879–94.
Scumpia AJ, Kafel J, Hallas BH, Horowitz JM, Torres G. Endothelial heat shock response in cerebral ischemia. Histol Histopathol. 2007;22:815–23.
Lindblom R, Tovedal T, Norlin B, Hillered L, Englund E, Thelin S. Mechanical reperfusion following prolonged global cerebral ischemia attenuates brain injury. J Cardiovasc Transl Res. 2021;14:338–47.
Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation. 2013;127:1980–5.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418.
Sekhon MS, Ainslie PN, Griesdale DE. Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a ‘two-hit’ model. Crit Care. 2017;21:90.
Chan DC. Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol. 2020;15:235–59.
Kleele T, Rey T, Winter J, Zaganelli S, Mahecic D, Perreten Lambert H, et al. Distinct fission signatures predict mitochondrial degradation or biogenesis. Nature. 2021;593:435–9.
Lewis SC, Uchiyama LF, Nunnari J. ER-mitochondria contacts couple mtDNA synthesis with mitochondrial division in human cells. Science. 2016;353:aaf5549.
Giacomello M, Pyakurel A, Glytsou C, Scorrano L. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020;21:204–24.
van der Bliek AM, Shen Q, Kawajiri S. Mechanisms of mitochondrial fission and fusion. Cold Spring Harb Perspect Biol. 2013;5:a011072.
Adebayo M, Singh S, Singh AP, Dasgupta S. Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis. FASEB J. 2021;35:e21620.
Axelrod CL, Fealy CE, Erickson ML, Davuluri G, Fujioka H, Dantas WS, et al. Lipids activate skeletal muscle mitochondrial fission and quality control networks to induce insulin resistance in humans. Metabolism. 2021;121:154803.
Li J, Jia YC, Ding YX, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19:2756–71.
Nielson JR, Rutter JP. Lipid-mediated signals that regulate mitochondrial biology. J Biol Chem. 2018;293:7517–21.
Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects. Cells. 2019;8:728.
Wang W, Li L, Wang X. Therapeutic targets during mitochondrial lipid metabolism. Cell Biol Toxicol. 2020;36:205–8.
Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482:419–25.
Kagan VE, Tyurina YY, Tyurin VA, Mohammadyani D, Angeli JP, Baranov SV, et al. Cardiolipin signaling mechanisms: collapse of asymmetry and oxidation. Antioxid Redox Signal. 2015;22:1667–80.
Huang KC, Mukhopadhyay R, Wingreen NS. A curvature-mediated mechanism for localization of lipids to bacterial poles. PLoS Comput Biol. 2006;2:e151.
Musatov A, Sedlák E. Role of cardiolipin in stability of integral membrane proteins. Biochimie. 2017;142:102–11.
Musatov A, Robinson NC. Bound cardiolipin is essential for cytochrome c oxidase proton translocation. Biochimie. 2014;105:159–64.
Thong A, Tsoukanova V. Cytochrome-c-assisted escape of cardiolipin from a model mitochondrial membrane. Biochim Biophys Acta Biomembr. 2018;1860:475–80.
Tyurina YY, Kini V, Tyurin VA, Vlasova II, Jiang J, Kapralov AA, et al. Mechanisms of cardiolipin oxidation by cytochrome c: relevance to pro- and antiapoptotic functions of etoposide. Mol Pharmacol. 2006;70:706–17.
Schlame M, Greenberg ML. Biosynthesis, remodeling and turnover of mitochondrial cardiolipin. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:3–7.
Xu Y, Malhotra A, Ren M, Schlame M. The enzymatic function of tafazzin*. J Biol Chem. 2006;281:39217–24.
Duncan AL. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins. Biochem Soc Trans. 2020;48:993–1004.
Bertero E, Kutschka I, Maack C, Dudek J. Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165803.
Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 2013;15:1197–205.
Hsu P, Liu X, Zhang J, Wang HG, Ye JM, Shi Y. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy. Autophagy. 2015;11:643–52.
Cid-Castro C, Hernández-Espinosa DR, Morán J. ROS as regulators of mitochondrial dynamics in neurons. Cell Mol Neurobiol. 2018;38:995–1007.
Kraus F, Roy K, Pucadyil TJ, Ryan MT. Function and regulation of the divisome for mitochondrial fission. Nature. 2021;590:57–66.
Pegadraju H, Abby Thomas J, Kumar R. Mechanistic and therapeutic role of Drp1 in the pathogenesis of stroke. Gene. 2023;855:147130.
Shi W, Tan C, Liu C, Chen D. Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases. Rev Neurosci. 2023;34:275–94.
Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007;8:939–44.
Valera-Alberni M, Joffraud M, Miro-Blanch J, Capellades J, Junza A, Dayon L, et al. Crosstalk between Drp1 phosphorylation sites during mitochondrial remodeling and their impact on metabolic adaptation. Cell Rep. 2021;36:109565.
Han X-J, Lu YF, Li SA, Kaitsuka T, Sato Y, Tomizawa K, et al. CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol. 2008;182:573–85.
Losón OC, Song Z, Chen H, Chan DC. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24:659–67.
Yang J, Chen P, Cao Y, Liu S, Wang W, Li L, et al. Chemical inhibition of mitochondrial fission via targeting the DRP1-receptor interaction. Cell Chem Biol. 2023;30:278–94.e11.
Moyzis AG, Lally NS, Liang W, Leon LJ, Najor RH, Orogo AM, et al. Mcl-1-mediated mitochondrial fission protects against stress but impairs cardiac adaptation to exercise. J Mol Cell Cardiol. 2020;146:109–20.
Kornfeld OS, Qvit N, Haileselassie B, Shamloo M, Bernardi P, Mochly-Rosen D. Interaction of mitochondrial fission factor with dynamin related protein 1 governs physiological mitochondrial function in vivo. Sci Rep. 2018;8:14034.
Liu A, Kage F, Higgs HN. Mff oligomerization is required for Drp1 activation and synergy with actin filaments during mitochondrial division. Mol Biol Cell. 2021;32:ar5.
Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol. 2010;191:1141–58.
Liu R, Chan DC. The mitochondrial fission receptor Mff selectively recruits oligomerized Drp1. Mol Biol Cell. 2015;26:4466–77.
Adachi Y, Itoh K, Yamada T, Cerveny KL, Suzuki TL, Macdonald P, et al. Coincident phosphatidic acid interaction restrains Drp1 in mitochondrial division. Mol Cell. 2016;63:1034–43.
Ingerman E, Perkins EM, Marino M, Mears JA, McCaffery JM, Hinshaw JE, et al. Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol. 2005;170:1021–7.
Kalia R, Wang RY, Yusuf A, Thomas PV, Agard DA, Shaw JM, et al. Structural basis of mitochondrial receptor binding and constriction by DRP1. Nature. 2018;558:401–5.
Yu T, Fox RJ, Burwell LS, Yoon Y. Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1. J Cell Sci. 2005;118:4141–51.
Wang S, Zhu H, Li R, Mui D, Toan S, Chang X, et al. DNA-PKcs interacts with and phosphorylates Fis1 to induce mitochondrial fragmentation in tubular cells during acute kidney injury. Sci Signal. 2022;15:eabh1121.
Zou R, Shi W, Qiu J, Zhou N, Du N, Zhou H, et al. Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis. Cardiovasc Diabetol. 2022;21:106.
Morciano G, Giorgi C, Balestra D, Marchi S, Perrone D, Pinotti M, et al. Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death. Mol Biol Cell. 2016;27:20–34.
Germain M, Nguyen AP, Le Grand JN, Arbour N, Vanderluit JL, Park DS, et al. MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner. EMBO J. 2011;30:395–407.
Mahajan M, Bharambe N, Shang Y, Lu B, Mandal A, Madan Mohan P, et al. NMR identification of a conserved Drp1 cardiolipin-binding motif essential for stress-induced mitochondrial fission. Proc Natl Acad Sci. 2021;118:e2023079118.
Francy CA, Clinton RW, Fröhlich C, Murphy C, Mears JA. Cryo-EM studies of drp1 reveal cardiolipin interactions that activate the helical oligomer. Sci Rep. 2017;7:10744.
Stepanyants N, Macdonald PJ, Francy CA, Mears JA, Qi X, Ramachandran R. Cardiolipin’s propensity for phase transition and its reorganization by dynamin-related protein 1 form a basis for mitochondrial membrane fission. Mol Biol Cell. 2015;26:3104–16.
Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol. 2003;160:189–200.
Jahani-Asl A, Cheung EC, Neuspiel M, MacLaurin JG, Fortin A, Park DS, et al. Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death. J Biol Chem. 2007;282:23788–98.
Qi Y, Yan L, Yu C, Guo X, Zhou X, Hu X, et al. Structures of human mitofusin 1 provide insight into mitochondrial tethering. J Cell Biol. 2016;215:621–9.
Jones E, Gaytan N, Garcia I, Herrera A, Ramos M, Agarwala D, et al. A threshold of transmembrane potential is required for mitochondrial dynamic balance mediated by DRP1 and OMA1. Cell Mol Life Sci. 2017;74:1347–63.
Shutt T, Geoffrion M, Milne R, McBride HM. The intracellular redox state is a core determinant of mitochondrial fusion. EMBO Rep. 2012;13:909–15.
Lee J-Y, Kapur M, Li M, Choi MC, Choi S, Kim HJ, et al. MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria. J Cell Sci. 2014;127:4954–63.
Ishihara N, Maeda M, Ban T, Mihara K. Cell-free mitochondrial fusion assay detected by specific protease reaction revealed Ca2+ as regulator of mitofusin-dependent mitochondrial fusion. J Biochem. 2017;162:287–94.
Del Dotto V, Mishra P, Vidoni S, Fogazza M, Maresca A, Caporali L, et al. OPA1 isoforms in the hierarchical organization of mitochondrial functions. Cell Rep. 2017;19:2557–71.
Wang R, Mishra P, Garbis SD, Moradian A, Sweredoski MJ, Chan DC. Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion. Mol Biol Cell. 2021;32:157–68.
Ge Y, Shi X, Boopathy S, McDonald J, Smith AW, Chao LH. Two forms of Opa1 cooperate to complete fusion of the mitochondrial inner-membrane. eLife. 2020;9:e50973.
Mishra P, Carelli V, Manfredi G, Chan DC. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 2014;19:630–41.
Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol. 2014;204:919–29.
Lee H, Smith SB, Yoon Y. The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure. J Biol Chem. 2017;292:7115–30.
Fogo GM, Raghunayakula S, Emaus KJ, Torres Torres FJ, Wider JM, Sanderson TH. Mitochondrial membrane potential and oxidative stress interact to regulate Oma1-dependent processing of Opa1 and mitochondrial dynamics. FASEB J. 2024;38:e70066.
Darshi M, Mendiola VL, Mackey MR, Murphy AN, Koller A, Perkins GA, et al. ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J Biol Chem. 2011;286:2918–32.
Gómez LA, Hagen TM. Age-related decline in mitochondrial bioenergetics: does supercomplex destabilization determine lower oxidative capacity and higher superoxide production?. Semin Cell Dev Biol. 2012;23:758–67.
Ban T, Ishihara T, Kohno H, Saita S, Ichimura A, Maenaka K, et al. Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin. Nat Cell Biol. 2017;19:856–63.
Ban T, Kohno H, Ishihara T, Ishihara N. Relationship between OPA1 and cardiolipin in mitochondrial inner-membrane fusion. Biochim Biophys Acta BBA - Bioenerg. 2018;1859:951–7.
Kumar R, Bukowski MJ, Wider JM, Reynolds CA, Calo L, Lepore B, et al. Mitochondrial dynamics following global cerebral ischemia. Mol Cell Neurosci. 2016;76:68–75.
Li X, Li H, Xu Z, Ma C, Wang T, You W, et al. Ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons. Cell Death Dis. 2022;13:321.
Wu B, Luo H, Zhou X, Cheng CY, Lin L, Liu BL, et al. Succinate-induced neuronal mitochondrial fission and hexokinase II malfunction in ischemic stroke: therapeutical effects of kaempferol. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2307–18.
Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci. 2007;27:1129–38.
Balog J, Mehta SL, Vemuganti R. Mitochondrial fission and fusion in secondary brain damage after CNS insults. J Cereb Blood Flow Metab. 2016;36:2022–33.
Kislin M, Sword J, Fomitcheva IV, Croom D, Pryazhnikov E, Lihavainen E, et al. Reversible disruption of neuronal mitochondria by ischemic and traumatic injury revealed by quantitative two-photon imaging in the neocortex of anesthetized mice. J Neurosci J Soc Neurosci. 2017;37:333–48.
Nair S, Leverin AL, Rocha-Ferreira E, Sobotka KS, Thornton C, Mallard C, et al. Induction of mitochondrial fragmentation and mitophagy after neonatal hypoxia-ischemia. Cells. 2022;11:1193.
Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, et al. Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice. J Nanobiotechnol. 2022;20:256.
Wan R, Fan J, Song H, Sun W, Yin Y. Oxygen-glucose deprivation/reperfusion-induced sirt3 reduction facilitated neuronal injuries in an apoptosis-dependent manner during prolonged reperfusion. Neurochem Res. 2022;47:1012–24.
Flippo KH, Lin Z, Dickey AS, Zhou X, Dhanesha NA, Walters GC, et al. Deletion of a neuronal Drp1 activator protects against cerebral ischemia. J Neurosci. 2020;40:3119–29.
Grohm J, Kim SW, Mamrak U, Tobaben S, Cassidy-Stone A, Nunnari J, et al. Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ. 2012;19:1446–58.
Peng C, Rao W, Zhang L, Wang K, Hui H, Wang L, et al. Mitofusin 2 ameliorates hypoxia-induced apoptosis via mitochondrial function and signaling pathways. Int J Biochem Cell Biol. 2015;69:29–40.
Peng C, Rao W, Zhang L, Gao F, Hui H, Wang K, et al. Mitofusin 2 exerts a protective role in ischemia reperfusion injury through increasing autophagy. Cell Physiol Biochem. 2018;46:2311–24.
Sun Y, Xue W, Song Z, Huang K, Zheng L. Restoration of Opa1-long isoform inhibits retinal injury-induced neurodegeneration. J Mol Med. 2016;94:335–46.
Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013;20:31–42.
Sugiura A, McLelland G-L, Fon EA, McBride HM. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014;33:2142–56.
Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol. 2010;189:211–21.
Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, et al. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem. 2003;278:31469–72.
Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8:e1000298.
Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309–14.
Okatsu K, Koyano F, Kimura M, Kosako H, Saeki Y, Tanaka K, et al. Phosphorylated ubiquitin chain is the genuine Parkin receptor. J Cell Biol. 2015;209:111–28.
Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl. Acad Sci USA. 2010;107:378–83.
Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol. 2014;205:143–53.
Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, et al. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem J. 2014;460:127–39.
Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 2014;510:162–6.
Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet. 2011;20:1726–37.
Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010;12:119–31.
Vranas M, Lu Y, Rasool S, Croteau N, Krett JD, Sauvé V, et al. Selective localization of Mfn2 near PINK1 enables its preferential ubiquitination by Parkin on mitochondria. Open Biol. 2022;12:210255.
Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol. 2010;191:1367–80.
Yoshii SR, Kishi C, Ishihara N, Mizushima N. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem. 2011;286:19630–40.
Heo J-M, Ordureau A, Paulo JA, Rinehart J, Harper JW. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 2015;60:7–20.
Kataura T, Otten EG, Rabanal-Ruiz Y, Adriaenssens E, Urselli F, Scialo F, et al. NDP52 acts as a redox sensor in PINK1/Parkin-mediated mitophagy. EMBO J. 2023;42:e111372.
Matsumoto G, Shimogori T, Hattori N, Nukina N. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet. 2015;24:4429–42.
Nguyen TN, Sawa-Makarska J, Khuu G, Lam WK, Adriaenssens E, Fracchiolla D, et al. Unconventional initiation of PINK1/Parkin mitophagy by Optineurin. Mol Cell. 2023;83:1693–709.e9.
Richard T, Herzog LK, Vornberger J, Rahmanto AS, Sangfelt O, Salomons FA, et al. K63-linked ubiquitylation induces global sequestration of mitochondria. Sci Rep. 2020;10:22334.
Rogers RS, Tungtur S, Tanaka T, Nadeau LL, Badawi Y, Wang H, et al. Impaired mitophagy plays a role in denervation of neuromuscular junctions in ALS mice. Front Neurosci. 2017;11:473.
Chao H, Anthonymuthu TS, Kenny EM, Amoscato AA, Cole LK, Hatch GM, et al. Disentangling oxidation/hydrolysis reactions of brain mitochondrial cardiolipins in pathogenesis of traumatic injury. JCI Insight. 2018;3:e97677 97677.
Van Q, Liu J, Lu B, Feingold KR, Shi Y, Lee RM, et al. Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells. Biochem J. 2007;401:103–9.
Huang W, Choi W, Hu W, Mi N, Guo Q, Ma M, et al. Crystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding protein. Cell Res. 2012;22:473–89.
Wider JM, Gruley E, Morse PT, Wan J, Lee I, Anzell AR, et al. Modulation of mitochondrial function with near-infrared light reduces brain injury in a translational model of cardiac arrest. Crit Care. 2023;27:491.
Wojtyniak P, Boratynska-Jasinska A, Serwach K, Gruszczynska-Biegala J, Zablocka B, Jaworski J, et al. Mitofusin 2 integrates mitochondrial network remodelling, mitophagy and renewal of respiratory chain proteins in neurons after oxygen and glucose deprivation. Mol Neurobiol. 2022;59:6502–18.
Zhang X, Yan H, Yuan Y, Gao J, Shen Z, Cheng Y, et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy. 2013;9:1321–33.
Zuo W, Zhang S, Xia CY, Guo XF, He WB, Chen NH. Mitochondria autophagy is induced after hypoxic/ischemic stress in a Drp1 dependent manner: the role of inhibition of Drp1 in ischemic brain damage. Neuropharmacology. 2014;86:103–15.
Lan R, Wu JT, Wu T, Ma YZ, Wang BQ, Zheng HZ, et al. Mitophagy is activated in brain damage induced by cerebral ischemia and reperfusion via the PINK1/Parkin/p62 signalling pathway. Brain Res Bull. 2018;142:63–77.
Zhang X, Wei M, Fan J, Yan W, Zha X, Song H, et al. Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons. Autophagy. 2021;17:1519–42.
Siddall HK, Yellon DM, Ong SB, Mukherjee UA, Burke N, Hall AR, et al. Loss of PINK1 increases the heart’s vulnerability to ischemia-reperfusion injury. PloS One. 2013;8:e62400.
Wen Y, Gu Y, Tang X, Hu Z. PINK1 overexpression protects against cerebral ischemia through Parkin regulation. Environ Toxicol. 2020;35:188–93.
Chen N, Guo Z, Luo Z, Zheng F, Shao W, Yu G, et al. Drp1-mediated mitochondrial fission contributes to mitophagy in paraquat-induced neuronal cell damage. Environ Pollut. 2021;272:116413.
Frank M, Duvezin-Caubet S, Koob S, Occhipinti A, Jagasia R, Petcherski A, et al. Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim Biophys Acta. 2012;1823:2297–310.
Gomes LC, Scorrano L. High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy. Biochim Biophys Acta. 2008;1777:860–6.
Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008;27:433–46.
Tang J, Hu Z, Tan J, Yang S, Zeng L. Parkin protects against oxygen-glucose deprivation/reperfusion insult by promoting Drp1 degradation. Oxid Med Cell Longev. 2016;2016:8474303.
Wen H, Zuo Y, Li L, Zhan L, Xue J, Sun W, et al. Hypoxic postconditioning restores mitophagy against transient global cerebral ischemia via Parkin-induced posttranslational modification of TBK1. Neurobiol Dis. 2023;179:106043.
Burman JL, Pickles S, Wang C, Sekine S, Vargas J, Zhang Z, et al. Mitochondrial fission facilitates the selective mitophagy of protein aggregates. J Cell Biol. 2017;216:3231–47.
Goldsmith J, Ordureau A, Harper JW, Holzbaur ELF. Brain-derived autophagosome profiling reveals the engulfment of nucleoid-enriched mitochondrial fragments by basal autophagy in neurons. Neuron. 2022;110:967–76.e8.
König T, Nolte H, Aaltonen MJ, Tatsuta T, Krols M, Stroh T, et al. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. Nat Cell Biol. 2021;23:1271–86.
McLelland G-L, Goiran T, Yi W, Dorval G, Chen CX, Lauinger ND, et al. Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. eLife. 2018;7:e32866.
Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell. 2010;141:656–67.
Park K-S, Wiederkehr A, Kirkpatrick C, Mattenberger Y, Martinou JC, Marchetti P, et al. Selective actions of mitochondrial fission/fusion genes on metabolism-secretion coupling in insulin-releasing cells. J Biol Chem. 2008;283:33347–56.
Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T, Takahashi R. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ. 2004;11:208–16.
Vos M, Geens A, Böhm C, Deaulmerie L, Swerts J, Rossi M, et al. Cardiolipin promotes electron transport between ubiquinone and complex I to rescue PINK1 deficiency. J Cell Biol. 2017;216:695–708.
Chen BB, Coon TA, Glasser JR, Zou C, Ellis B, Das T, et al. E3 Ligase subunit Fbxo15 and PINK1 kinase regulate cardiolipin synthase 1 stability and mitochondrial function in pneumonia. Cell Rep. 2014;7:476–87.
Schlame M, Ren M. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim Biophys Acta. 2009;1788:2080–3.
Petrosillo G, Casanova G, Matera M, Ruggiero FM, Paradies G. Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: induction of permeability transition and cytochrome c release. FEBS Lett. 2006;580:6311–6.
Zhou S, Taskintuna K, Hum J, Gulati J, Olaya S, Steinman J, et al. PGC-1α repression dysregulates lipid metabolism and induces lipid droplet accumulation in the retinal pigment epithelium. Cell Death Dis. 2024;15:1–15.
Oemer G, Koch J, Wohlfarter Y, Alam MT, Lackner K, Sailer S, et al. Phospholipid acyl chain diversity controls the tissue-specific assembly of mitochondrial cardiolipins. Cell Rep. 2020;30:4281–91.e4.
Falabella M, Vernon HJ, Hanna MG, Claypool SM, Pitceathly RDS. Cardiolipin, mitochondria, and neurological disease. Trends Endocrinol Metab. 2021;32:224–37.
Anthonymuthu TS, Kenny EM, Hier ZE, Clark R, Kochanek PM, Kagan VE, et al. Detection of brain specific cardiolipins in plasma after experimental pediatric head injury. Exp Neurol. 2019;316:63–73.
Anthonymuthu TS, Kenny EM, Lamade AM, Gidwani H, Krehel NM, Misse A, et al. Lipidomics detection of brain cardiolipins in plasma is associated with outcome after cardiac arrest. Crit Care Med. 2019;47:e292–e300.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Paolo Pinton
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Emaus, K.J., Fogo, G.M., Wider, J.M. et al. The role of cardiolipin in mitochondrial dynamics and quality control in neuronal ischemia/reperfusion injury. Cell Death Dis 16, 494 (2025). https://doi.org/10.1038/s41419-025-07786-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-025-07786-8
This article is cited by
-
Electroacupuncture Improves Pregnancy Outcomes of Assisted Reproduction and Mitochondrial Function of Granulosa Cells in Patients with Polycystic Ovary Syndrome of Phlegm-Dampness Syndrome
Chinese Journal of Integrative Medicine (2025)